In both healthcare and business, success doesn’t come from chance—it comes from preparation. The organizations that thrive are the ones that don’t just act but also step back to optimize and plan before the competition.
Momentum Doesn’t Wait for January
Many leaders treat strategic planning as a December or January exercise. The problem? By then, the market has already shifted, competitors have acted, and opportunities may have passed.
Momentum isn’t created by reacting late. It’s built proactively, with thoughtful planning done before the year closes.
That’s why September—when there’s still time to assess results, adjust strategies, and prepare for the year ahead—is the best moment to get ahead.
From Implementation to Optimization
Implementing a solution is only the starting point. The real gains come when organizations:
Optimize what’s working so it delivers even greater impact.
Evolve what isn’t so that weaknesses don’t carry into the next year.
Build readiness to adapt quickly when new challenges and opportunities appear.
This is where the investment of time and resources begins to generate compounding returns.
Why Early Planning Wins
Getting started before the year closes delivers three major advantages:
Clarity: You’ll know what’s effective—and what isn’t—while there’s still time to adjust.
Momentum: January becomes a launchpad, not a scramble.
Confidence: Teams can execute with focus instead of reacting under pressure.
Ready to Lead, Not React
September isn’t just another month—it’s a turning point. By planning early, organizations can enter the new year with clarity, alignment, and a competitive edge.
Your 2026 success story doesn’t start in January. It starts now.
Sales Augmentation: Smarter Strategies for Field Success
/
RSS Feed
Share
Link
Embed
Connexio Health shares how sales augmentation addresses stretched field teams. Learn why the 80/20 rule leaves accounts underserved, and how pairing strategies improve coverage, efficiency, and growth without burning out teams.
In-Person vs. Virtual Account Management: Settling the Debate
/
RSS Feed
Share
Link
Embed
Explore the pros and cons of in-person, virtual, and hybrid account management in healthcare. Learn how organizations strike balance and discover what truly drives stronger relationships and better outcomes.
In today’s rapidly evolving healthcare landscape, reaching the right stakeholders with the right message at the right time is more complex than ever. Field teams remain a cornerstone of engagement, but even the most seasoned representatives face limitations—time, geography, access, and bandwidth. As we strive for more meaningful, sustained connections in an omnichannel world, Virtual Account Management (VAM) has emerged as a powerful complement, enabling organizations to expand their reach, deepen relationships, and unlock new levels of performance.
The Case for Virtual Account Management
While field teams offer invaluable face-to-face interaction, they often face access restrictions, particularly in specialty areas where providers are time-constrained or dispersed. Virtual Account Management fills critical gaps, allowing healthcare organizations to:
Maintain continuity between in-person visits through strategic digital touchpoints.
Engage hard-to-reach providers who may not be accessible through traditional rep channels.
Prioritize accounts more intelligently, focusing high-touch field resources where they’ll have the greatest impact.
With a VAM layer in place, teams can extend coverage, deliver consistent messaging, and adapt more nimbly to the evolving access environment.
Field + Virtual: A Force Multiplier
When done right, virtual account managers do more than echo field messages—they amplify them. This hybrid model fosters coordination and balance between roles:
Field reps focus on high-value, relationship-driven engagements.
Virtual managers reinforce brand messaging, address follow-up needs, and introduce new resources across multiple channels.
Together, they create a surround-sound experience that fosters trust and guides providers through the decision-making process.
Data-Driven Precision
Integrating virtual account management with data intelligence tools—such as predictive segmentation, whitespace identification, and next-best-action algorithms—supercharges targeting strategies. By leveraging insights from prescribing trends, engagement history, and clinical behavior, organizations can determine:
Which accounts warrant in-person vs. virtual engagement?
What content resonates best at each stage of the provider journey?
How to time and sequence interactions for maximum impact.
This kind of precision ensures field and virtual teams operate in lockstep, reducing redundancy and boosting ROI.
Results That Speak
Healthcare organizations that adopt hybrid models often report measurable gains:
Improved coverage across under-engaged territories.
Increased HCP engagement rates, particularly among digitally native or access-limited specialists.
Enhanced agility, allowing commercial teams to pivot rapidly in response to market changes or product needs.
In short, virtual account management isn’t a replacement for field force—it’s an evolution. One that empowers teams to work smarter, adapt faster, and ultimately deliver better outcomes for providers and patients alike.
Closing Thought
In an era where personalization, access, and agility reign supreme, augmenting field teams with virtual account management is not just a trend—it’s a transformation. Those who embrace this model will find themselves better equipped to meet the moment—and the future—of healthcare engagement.
Building a Predictable Revenue Engine from the Ground Up
Executive Summary
For MedTech startups navigating the complexities of commercialization, an accurate sales forecast is not just a numbers game; it’s a strategic imperative. Sales forecasts fuel investor confidence, inform staffing decisions, shape marketing strategies, and ultimately, dictate the pace of market entry. This whitepaper offers a structured approach to sales forecasting tailored to emerging medical technology companies, focusing on the key drivers, decision points, and process dynamics that shape successful go-to-market plans.
1. Start with the Right Questions
Before you input a single number into a model, consider the following foundational questions:
Who are your target customers—new vs. existing, clinics vs. health systems?
Estimate annual revenue per customer using baseline pricing, order frequency, and contract terms.
What’s your expected ramp-up period? Revenue doesn’t start on Day 1 — forecast gradual adoption.
How long is your sales cycle? Factor in the delay from campaign launch to first purchase.
How efficient is your team at converting? Yield follows execution.
2. The Process Yield Funnel: Define Your Commercial Steps
The model in your spreadsheet uses a Yield-Based Sales Funnel that breaks down the customer acquisition process into conversion stages. This gives startups clarity on where pipeline attrition happens — and how much activity is required to hit revenue targets.
Sample Funnel for Existing Customers (Upsell):
Step
Description
Example Yield
Campaign Target
Total contacts engaged
100%
Decision Maker Reached
Contacts reached
60%
Opportunity Identified
Qualified interest
50%
Product Demo
Engaged leads
75%
Sale
Closed deals
30%
This example results in a 6.75% overall conversion rate (0.6 × 0.5 × 0.75 × 0.3), meaning you’ll need to start with ~15 prospects for every sale
What If You Don’t Have Benchmarks?
Many MedTech startups lack historical data early on. In this case, apply the 10:3:1 Rule:
* For every 10 people you talk to, 3 will be interested, and 1 will buy.
This rule of thumb is a reliable proxy to model early activity until actual conversion metrics emerge. It equates to a 10% close rate on total outreach.
Application Example:
If your goal is 100 new customers, then:
You’ll need 300 qualified leads (expressed interest)
Which means reaching out to 1,000 prospects
Use this rule to estimate:
How many prospects you need in your CRM
How many outreach messages or calls does your team execute
How much staffing and tooling is needed to support your top-of-funnel volume
3. Account for Ramp-Up: Reality vs. Optimism
One of the most overlooked aspects in startup sales forecasts is the time lag between launch and scale. Your model smartly includes:
Ramp-up percentages per month (e.g., 2%, 4%, … up to 12%)
Cumulative customer adds
Corresponding monthly revenue growth
This reflects real-world adoption patterns, particularly in healthcare, where provider trust, procurement cycles, and clinical validation all cause friction.
Recommendation: Use a conservative ramp profile, and validate with similar MedTech analogs if possible. Over-forecasting Month 1 revenue is a rookie mistake.
4. Understand Revenue Sources
MedTech companies typically derive revenue from:
Baseline Revenue: Pre-existing customer base
New Customer Acquisition: Fresh accounts converted from cold outreach
Upsell/Cross-Sell: Expanding wallet share from current users
Your model includes average order value, monthly value per customer, and projected upsell impact (e.g., 10%). Use industry benchmarks but validate with pilot data or early customers when possible.
5. Staffing and Capacity Assumptions
Your ability to reach, convert, and retain customers depends on team capacity. Use the following logic:
Rep Productivity: How many demos or sales calls per week?
Lead Coverage: Do you have enough SDRs to reach the entire campaign target?
CSM Load: Who manages existing accounts for upsell?
Pro Tip: Forecast sales and support team growth in sync with your revenue ramp. Overhiring too early kills runway. Underhiring bottlenecks growth.
6. KPIs to Track and Refine
Every forecast should come with a feedback loop:
Conversion rates at each funnel stage
Actual vs. forecasted new customers
List item
Customer acquisition cost (CAC)
Revenue per rep and rep ramp time
Payback period on sales spend
Conclusion
Sales forecasting for MedTech startups is not just about math. It’s about thinking critically through your commercial assumptions, mapping the buyer journey, and designing a funnel that aligns with real market behavior. The included model offers a robust foundation, but your ongoing discipline in testing, learning, and adjusting is what will ultimately ensure success.
Tariffs may seem like geopolitical headlines or economic policy levers, but they have immediate and measurable effects for healthcare manufacturers. From increasing costs on essential materials to forcing shifts in commercialization models, tariffs can dramatically alter go-to-market strategies.
At Connexio Health, we help medical device, pharmaceutical, diagnostic, and biotech innovators respond to disruption with agility. Here’s what healthcare manufacturers need to know—and do—when tariffs are in play.
The True Cost of Tariffs in Healthcare
Tariffs are government-imposed duties on imported goods. When these apply to materials used in healthcare products, such as electronic components, active pharmaceutical ingredients, or packaging supplies, they impact everything from unit economics to launch timelines.
A diagnostic manufacturer sourcing overseas electronic parts may face higher costs and delays. A pharmaceutical company reliant on foreign ingredients could see its supply chain destabilized. Even if a product is entirely U.S.-made, packaging, shipping,g and labeling components might still be tariff-affected.
These impacts extend beyond the supply chain. Increased costs may erode the margin or require price adjustments. For provider organizations under value-based care pressures, this can create friction, especially when outcomes, reimbursement, and budgets are under scrutiny.
The Commercial Model Under Pressure
Research from the Alexander Group shows how leading companies react to tariff-induced disruptions. According to their findings, 83 percent of affected firms permanently adjusted their commercial strategies. These changes include:
Accelerated use of virtual sales and account management models
Tighter account segmentation to focus on high-margin opportunities
Investment in analytics to optimize territory planning and resource deployment
This shift isn’t temporary. As global instability, inflation, and tariff risk persist, manufacturers must design commercial models that flex and adapt.
Three Moves to Make Right Now
Whether your company is already feeling the impact of tariffs or simply planning for volatility, there are immediate steps you can take:
1. Audit Your Supply Chain
Map your current supplier base and assess exposure to tariff-related cost increases. Consider alternatives or backup sources that allow for faster pivots.
2. Rethink Pricing and Profitability
Work with your finance and sales leadership to review pricing models. Where are margins at risk? What are the thresholds your customer base will tolerate? Consider bundling, subscription models, or value-based pricing structures.
3. Reposition Your Sales Messaging
Equip your commercial teams with messaging that highlights product value, clinical outcomes, and economic benefit. With many providers operating under tighter budgets, clarity around total cost of ownership and ROI is critical.
The Connexio Health Advantage
At Connexio Health, we specialize in commercialization strategies that account for complexity. Whether you’re launching into a competitive space, navigating uncertain economic conditions, or realigning your sales force, we bring the insights and execution support you need to stay ahead.
Tariffs may be outside your control, but how you respond is not. Now is the time to assess, adapt, and accelerate.
To learn more about commercialization strategies that accelerate success, visit connexiohealth.com.
In today’s rapidly evolving healthcare landscape, staying ahead of the curve is more crucial than ever. At Connexio Health, we recognize that traditional methods of healthcare commercialization are not enough in an era where data drives decisions. That’s why we use an approach that harnesses the power of data, technology, and human intelligence to transform how healthcare products and services are brought to market.
The Challenge of Healthcare Commercialization
Healthcare commercialization is a complex and multifaceted process. It involves a deep understanding of diverse market needs and engaging with various stakeholders, from healthcare professionals to patients. Traditional strategies often fall short, as they rely heavily on intuition and experience rather than data-driven insights
Our Data-Driven Solution
The need for a more sophisticated approach is clear as the healthcare industry becomes increasingly data-rich. Companies that fail to leverage data effectively risk falling behind, missing out on opportunities to connect with their target audiences and maximize their market impact.
That’s why we use a comprehensive, data-driven approach to healthcare commercialization that addresses these challenges head-on. Here’s how we’re making a difference:
Deep Market Insights
Our approach begins with a thorough analysis of market data. We dive deep into industry trends, competitor activities, and customer behavior to uncover valuable insights that inform our strategies. By understanding the unique needs and preferences of different market segments, we can tailor our commercialization efforts to resonate with the right audiences.
Advanced Targeting and Segmentation
Data allows us to go beyond broad demographics and target specific groups with precision. We use advanced algorithms and predictive analytics to identify the healthcare professionals and patients most likely to benefit from our client’s products and services. This targeted approach ensures that our marketing and educational efforts are both effective and efficient.
Personalized Engagement
Today’s healthcare professionals expect personalized interactions. Our data-driven approach enables us to deliver tailored content and experiences that meet the individual needs of each healthcare professional. Whether through virtual clinical education, targeted marketing campaigns, or customized product information, we ensure that every touchpoint is relevant and impactful.
Continuous Optimization
The healthcare market is dynamic, and our strategies are designed to be agile. We continuously monitor and analyze data to assess the performance of our campaigns. This real-time feedback allows us to make informed adjustments, optimizing our efforts to achieve the best possible outcomes for our clients.
Bridging the Gap with Human Intelligence
While data is at the core of our approach, we understand that human intelligence remains irreplaceable. Our team of experts combines data-driven insights with deep industry knowledge to create strategies that are innovative and practical. We believe that the best results come from the synergy of data and human expertise.
The Future of Healthcare Commercialization
As the healthcare industry continues to evolve, the strategies we use to bring products and services to market must also evolve. At Connexio Health, we’re committed to staying at the forefront of this evolution. Our data-driven approach is just the beginning—we’re constantly exploring new ways to leverage technology and data to drive better outcomes for our clients.
Explore Our Approach
If you’re ready to take your healthcare commercialization efforts to the next level, contact Connexio Health today. Let’s work together to harness the power of data and innovation to achieve exceptional results.
Data is the new gold in the healthcare industry, and leveraging it effectively has a significant advantage. Here are five ways to use data to boost your healthcare sales:
Target the Right Audience: Move beyond traditional demographics. Utilize healthcare claims data to identify facilities with a high prevalence of conditions your product addresses. Combine this with information on purchasing history and existing contracts to pinpoint ideal customers with specific unmet needs.
Personalize Your Pitch: Data allows you to tailor your message to each prospect. Analyze their past purchases and research papers published by their staff to understand their current challenges and how your product aligns with their specific goals.
Predict Needs and Proactively Engage: Healthcare data can reveal trends in disease prevalence or upcoming regulatory changes at a facility. Use this foresight to reach out with solutions that address these anticipated needs proactively.
Measure Campaign Effectiveness: Data goes beyond lead generation. Track how prospects interact with your marketing materials, online content, and sales calls. Analyze these metrics to refine your messaging and identify the most effective outreach strategies.
Optimize Pricing and Reimbursement Strategies: Utilize cost analysis data to demonstrate the cost-effectiveness of your product compared to existing solutions. This empowers you to confidently position your product based on its value proposition for patient outcomes and healthcare facility budgets.
By incorporating data into your sales approach, you can move from a reactive to a proactive stance. You’ll better understand your customers’ needs, deliver more relevant solutions, and ultimately close more deals.
